JASO, JA Solar Holdings Co., Ltd.
** JASO reported that it has entered into an agreement with Solarhybrid AG, a Germany-based project developer and general contractor for turn-key utility-scale solar power projects, to supply 19 MW of solar modules to Solarhybrid’s Allstedt I solar power plant in Halle, Germany. JASO is the exclusive solar module supplier to the project.
JASO expects total module shipments to Solarhybrid to reach approximately 40 MW in 2011, including 19 MW of modules for the Allstedt I project.
JASO is a leading manufacturer of high-performance solar power products. JASO sells its products to solar manufacturers worldwide, who assemble and integrate solar cells into modules and systems that convert sunlight into electricity for residential, commercial, and utility-scale power generation.
More about JASO at www.jasolar.com.
PPHM, Peregrine Pharmaceuticals Inc.
** PPHM provided an update from its randomized Phase II bavituximab study in patients infected with genotype-1 chronic hepatitis C virus.
Patients were randomized in the three-arm study to receive one of two doses of bavituximab (0.3mg/kg or 3mg/kg) or pegylated interferon alpha-2a, in combination with ribavirin.
According to PPHM, preliminary data from Phase II study shows antiviral activity and positive safety profile at both bavituximab doses evaluated.
PPHM is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections.
More about PPHM at www.peregrineinc.com.
HIL, Hill International, Inc.
** HIL reported that it has been awarded a contract by the Iraqi Ministry of Youth and Sports to provide project management services in connection with construction of the new Al Anbar Olympic Stadium in Al Anbar, Iraq. The two-year contract has an estimated value to Hill of approximately IQD 3.8 billion ($3.3 million).
HIL’s services will include design review, site supervision, resident engineering, project management and quality control.
HIL provides program management, project management, construction management and construction claims and consulting services.
More about HIL at www.hillintl.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.